Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction

NCT05992870 is registered in ClinicalTrials.gov with Hubei Cancer Hospital as lead sponsor.

NCT NCT05992870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05992870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction
Lead sponsor
Hubei Cancer Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 8, 2023
Completion date
October 31, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, implant breast reconstruction, neoadjuvant radiotherapy